Literature DB >> 29542383

Predisposition of six well-characterized microRNAs to syndesmophytes among Chinese patients with ankylosing spondylitis.

Wenxue Yang1,2, Xiaoping Yan1,3, Qisheng Xia4, Qingwen Tao1,3, Xiaowei Gan1, Yingze Zhang1, Zhihua Chen4, Weiping Kong1,3.   

Abstract

OBJECTIVES: We quantified the expression of six well-characterized microRNAs (miRNAs) in peripheral blood mononuclear cells to see whether they can predispose to syndesmophytes in ankylosing spondylitis (AS) patients.
METHODS: This is a cross-sectional study involving 46 AS patients (23/23 with/without syndesmophytes) and 22 healthy controls. miRNAs expression was quantified by real-time PCR.
RESULTS: Six examined miRNAs were comparably expressed between AS patients without syndesmophytes and healthy controls (p > .05). Relative to AS patients without syndesmophytes, patients with syndesmophytes had significantly higher levels of miR-29a, miR-335-5p, miR-27a and let-7i (p = .001, .002, .013 and .029, respectively). Nine significant contributors associated with syndesmophytes in AS, including smoking, AS duration, human leukocyte antigen B27, erythrocyte sedimentation rate, C-reactive protein, miR-335-5p, miR-27a, miR-218 and sacroiliitis, were identified. The addition of miR-335-5p, miR-27a and miR-218 can significantly improve the accuracy of baseline risk factors. Based on the nine significant contributors, a nomogram was constructed, with good prediction accuracy (C-index: 0.86, p < .001).
CONCLUSION: We provide evidence for the predisposition of miR-335-5p, miR-27a and miR-218 to syndesmophytes in AS patients, indicating a contributory role of miRNAs in the pathogenesis of syndesmophytes. Further validation is warranted.

Entities:  

Keywords:  Ankylosing spondylitis; MicroRNA; predisposition; risk; syndesmophyte

Mesh:

Substances:

Year:  2018        PMID: 29542383     DOI: 10.1080/14397595.2018.1453277

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  8 in total

Review 1.  Biomarker development for axial spondyloarthritis.

Authors:  Matthew A Brown; Zhixiu Li; Kim-Anh Lê Cao
Journal:  Nat Rev Rheumatol       Date:  2020-06-30       Impact factor: 20.543

2.  Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients naïve to anti-TNF therapy.

Authors:  Paola Reyes-Loyola; Pedro Rodríguez-Henríquez; Martha A Ballinas-Verdugo; Luis M Amezcua-Castillo; Yaneli Juárez-Vicuña; Valentín Jiménez-Rojas; Ricardo Márquez-Velasco; Fausto Sánchez-Muñoz; Luis M Amezcua-Guerra
Journal:  Clin Rheumatol       Date:  2019-03-25       Impact factor: 2.980

Review 3.  Biomarkers in axial spondyloarthritis and low back pain: a comprehensive review.

Authors:  John D Reveille
Journal:  Clin Rheumatol       Date:  2021-10-21       Impact factor: 2.980

4.  Down-regulated miR-495 can target programmed cell death 10 in ankylosing spondylitis.

Authors:  Wen-Juan Ni; Xiao-Min Leng
Journal:  Mol Med       Date:  2020-05-25       Impact factor: 6.354

5.  miRNA-451a and miRNA-125a Expression Levels in Ankylosing Spondylitis: Impact on Disease Diagnosis, Prognosis, and Outcomes.

Authors:  Dina Salem Fotoh; Rasha Ibrahim Noreldin; Mohamed Soliman Rizk; Maha Mohamed Elsabaawy; Heba Ahmed Esaily
Journal:  J Immunol Res       Date:  2020-12-28       Impact factor: 4.818

Review 6.  The Potential Role of Genetics, Environmental Factors, and Gut Dysbiosis in the Aberrant Non-Coding RNA Expression to Mediate Inflammation and Osteoclastogenic/Osteogenic Differentiation in Ankylosing Spondylitis.

Authors:  Hsien-Tzung Liao; Chang-Youh Tsai; Chien-Chih Lai; Song-Chou Hsieh; Yi-Syuan Sun; Ko-Jen Li; Chieh-Yu Shen; Cheng-Han Wu; Cheng-Hsun Lu; Yu-Min Kuo; Tzu-Hao Li; Chung-Tei Chou; Chia-Li Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-20

Review 7.  MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis.

Authors:  Francesca Motta; Andrea Pederzani; Maria Cristina Carena; Angela Ceribelli; Paul B Wordsworth; Maria De Santis; Carlo Selmi; Matteo Vecellio
Journal:  Curr Rheumatol Rep       Date:  2021-07-03       Impact factor: 4.592

8.  Exploring the Extracellular Vesicle MicroRNA Expression Repertoire in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with TNF Inhibitors.

Authors:  Joanna Wielińska; Rachel E Crossland; Piotr Łacina; Jerzy Świerkot; Bartosz Bugaj; Anne M Dickinson; Katarzyna Bogunia-Kubik
Journal:  Dis Markers       Date:  2021-09-30       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.